033 - PCSK9 Inhibitors - a podcast by Sean P. Kane, PharmD; Khyati Patel, PharmD

In this episode, we discuss PCSK9 inhibitors, a new drug class for LDL lowering, with a particular focus on alirocumab (Praluent).

Further episodes of HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

Further podcasts by Sean P. Kane, PharmD; Khyati Patel, PharmD

Website of Sean P. Kane, PharmD; Khyati Patel, PharmD